- How Can We Easily Measure Glycemic Variability in Diabetes Mellitus?
-
Chon S
- KMID: 1805893
- Diabetes Metab J.
- 2015 Apr;39(2):114-116.
- doi: 10.4093/dmj.2015.39.2.114
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
-
Seok H
- KMID: 1805901
- Diabetes Metab J.
- 2015 Apr;39(2):171-172.
- doi: 10.4093/dmj.2015.39.2.171
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Figure Correction. A Gut Feeling to Cure Diabetes: Potential Mechanisms of Diabetes Remission after Bariatric Surgery
-
Cho YM
- KMID: 1805903
- Diabetes Metab J.
- 2015 Apr;39(2):175-175.
- doi: 10.4093/dmj.2015.39.2.175
There was a spelling error in the Fig. 2. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
-
Sicras-Mainar A, Navarro-Artieda R
- KMID: 1805902
- Diabetes Metab J.
- 2015 Apr;39(2):173-174.
- doi: 10.4093/dmj.2015.39.2.173
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
-
Seok H, Huh JH, Kim HM, Lee BW, Kang ES, Lee HC, Cha BS
- KMID: 1805900
- Diabetes Metab J.
- 2015 Apr;39(2):164-170.
- doi: 10.4093/dmj.2015.39.2.164
BACKGROUND: Type 1 diabetes is associated with more severe glycemic variability and more frequent hypoglycemia than type 2 diabetes. Glycemic variability is associated with poor glycemic control and diabetic complications.... -
- CITED
-
- Close
- SHARE
-
- Close
- Selective Immunoglobulin A Deficiency in Type 1 Diabetes Mellitus: A Prevalence Study in Western Sicily (Italy)
-
Greco D, Maggio F
- KMID: 1805896
- Diabetes Metab J.
- 2015 Apr;39(2):132-136.
- doi: 10.4093/dmj.2015.39.2.132
BACKGROUND: The association between type 1 diabetes and immunoglobulin A deficiency (IgA-D) has long been recognized in many populations. The aim of this study was to assess the prevalence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
-
Jung JH, Tantry US, Gurbel PA, Jeong YH
- KMID: 1805892
- Diabetes Metab J.
- 2015 Apr;39(2):95-113.
- doi: 10.4093/dmj.2015.39.2.95
Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued... -
- CITED
-
- Close
- SHARE
-
- Close
- The Insulin Resistance but Not the Insulin Secretion Parameters Have Changed in the Korean Population during the Last Decade
-
Yang HK, Lee JH, Choi IY, Kwon HS, Shin JA, Jeong SH, Lee SH, Cho JH, Son HY, Yoon KH
- KMID: 1805894
- Diabetes Metab J.
- 2015 Apr;39(2):117-125.
- doi: 10.4093/dmj.2015.39.2.117
BACKGROUND: This study aimed to compare the patterns of insulin secretion and resistance between Korean subjects in the 1990s and 2000s. METHODS: Insulin secretion and resistance indices were calculated from subjects... -
- CITED
-
- Close
- SHARE
-
- Close
- Intensive Individualized Reinforcement Education Is Important for the Prevention of Hypoglycemia in Patients with Type 2 Diabetes
-
Yong YM, Shin KM, Lee KM, Cho JY, Ko SH, Yoon MH, Kim TW, Jeong JH, Park YM, Ko SH, Ahn YB
- KMID: 1805899
- Diabetes Metab J.
- 2015 Apr;39(2):154-163.
- doi: 10.4093/dmj.2015.39.2.154
BACKGROUND: We investigated whether an intensive individualized reinforcement education program could influence the prevention of hypoglycemic events in patients with type 2 diabetes. METHODS: From March 2013 to September 2013, patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Low Economic Status Is Identified as an Emerging Risk Factor for Diabetes Mellitus in Korean Men Aged 30 to 59 Years in Korean National Health and Nutrition Examination Survey 2008 to 2010
-
Koo BK, Kim SW, Yi KH, Moon MK
- KMID: 1805897
- Diabetes Metab J.
- 2015 Apr;39(2):137-146.
- doi: 10.4093/dmj.2015.39.2.137
BACKGROUND: We compared the association between economic status and the prevalence of diabetes mellitus (DM) using large nationwide datasets covering the previous 10 years in Korea. METHODS: We analyzed the association... -
- CITED
-
- Close
- SHARE
-
- Close
- Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased beta-Cell Function Similar to Impaired Glucose Tolerance
-
Oh TJ, Min SH, Ahn CH, Kim EK, Kwak SH, Jung HS, Park KS, Cho YM
- KMID: 1805898
- Diabetes Metab J.
- 2015 Apr;39(2):147-153.
- doi: 10.4093/dmj.2015.39.2.147
BACKGROUND: Subjects with normal glucose tolerance (NGT) who have a high 1-hour postload plasma glucose level (> or =155 mg/dL; NGT 1 hour-high) have been shown to be at higher... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features and Causes of Endogenous Hyperinsulinemic Hypoglycemia in Korea
-
Woo CY, Jeong JY, Jang JE, Leem J, Jung CH, Koh EH, Lee WJ, Kim MS, Park JY, Lee JB, Lee KU
- KMID: 1805895
- Diabetes Metab J.
- 2015 Apr;39(2):126-131.
- doi: 10.4093/dmj.2015.39.2.126
BACKGROUND: Endogenous hyperinsulinemic hypoglycemia (EHH) is characterized by an inappropriately high plasma insulin level, despite a low plasma glucose level. Most of the EHH cases are caused by insulinoma, whereas... -
- CITED
-
- Close
- SHARE
-
- Close
- New Drugs for Treating Dyslipidemia: Beyond Statins
-
Ahn CH, Choi SH
- KMID: 1805891
- Diabetes Metab J.
- 2015 Apr;39(2):87-94.
- doi: 10.4093/dmj.2015.39.2.87
Statins have been shown to be very effective and safe in numerous randomized clinical trials, and became the implacable first-line treatment against atherogenic dyslipidemia. However, even with optimal statin treatment,... -
- CITED
-
- Close
- SHARE
-
- Close
